Jacobio Pharma lines up Hong Kong IPO

biopharma_stocks_adobe_575x375.jpg
By Jonathan Breen
30 Nov 2020

Jacobio Pharmaceuticals is preparing to launch the roadshow for its Hong Kong IPO after winning approval to list from the city’ stock exchange last week.

The Chinese firm will test the appetite of the market through a period of pre-deal investor education with the help of IPO sponsors CICC and Goldman Sachs.

The company counts Chinese venture capital firm Qiming Venture Partners and Hillhouse among its pre-IPO investors.

Jacobio focuses on in-house ...

Already a subscriber?

Continue reading this article

Try full access to GlobalCapital

Free trial